U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H16N3O6S.Na
Molecular Weight 329.305
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLUTATHIONE SODIUM

SMILES

[Na+].N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C([O-])=O

InChI

InChIKey=QWXDICNEPRTOLR-GEMLJDPKSA-M
InChI=1S/C10H17N3O6S.Na/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16;/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19);/q;+1/p-1/t5-,6-;/m0./s1

HIDE SMILES / InChI

Molecular Formula C10H16N3O6S
Molecular Weight 306.316
Charge -1
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/23036594 | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ef475c9-7938-4870-b336-fb0c2dafb3cd | https://clinicaltrials.gov/ct2/show/NCT01450267

Glutathione (GSH, also called as reduced glutathione) is a tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes such as, glutathione reductase, glutathione peroxidases, peroxiredoxins. Glutathione S-transferases catalyse the conjugation of GSH via a sulfhydryl group to electrophilic centers on a wide variety of substrates in order to make the compounds more water-soluble. As a part of homeopathic product, glutathione is used for temporary relief of symptoms related to Free Radical Toxicity including tingling in hands and feet, mood changes, frequent colds, poor digestion, fatigue, and constipation. In addition, for temporary relief of pain in the back from urinating, constant urging and frequent urination, kidneys sensitive to pressure, and pain from back extending down the thigh. Glutathione is an important nutrient for brain function and loss of glutathione has been implicated in Parkinson's disease. In phase II of the clinical trial was investigated whether administration of either dose of glutathione, as a nasal spray, improves PD symptoms over time in a population of individuals with Parkinson's disease (PD). In addition in phase II of clinical trial was shown, that reduced glutathione, an ingredient of RayGel™, has been helpful in decreasing some radiation therapy side effects to the skin. Reduced glutathione plays a vital role in both making DNA and cell repair. Cystic fibrosis (CF) is the most common inherited disease among the Caucasian population with considerable morbidity and reduced life expectancy. Glutathione (GSH) represents the first-line defence of the lung against oxidative stress-induced cell injury. Therapeutic approaches with inhaled GSH could improve the reduced lung antioxidant capacity in order to counterbalance the oxidant stress linked to the chronic airway inflammation and bacterial infection.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Glutathione S-transferases
Target ID: P00390
Gene ID: 2936.0
Gene Symbol: GSR
Target Organism: Homo sapiens (Human)
Conditions
PubMed

PubMed

TitleDatePubMed
CD95-Mediated murine hepatic apoptosis requires an intact glutathione status.
1999 Jul
Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa.
1999 Jun 1
Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocytic cells.
2000 Apr 14
Mitochondrial adaptations to obesity-related oxidant stress.
2000 Jun 15
The catalytic Tyr-9 of glutathione S-transferase A1-1 controls the dynamics of the C terminus.
2000 Jun 9
Detection of phosphorylation-dependent interactions by far-western gel overlay.
2001
Assays for mitogen-activated protein kinase (MAPK) subtypes and MAPK activating protein kinase-2 (MAPKAP K-2) using a common cell lysate.
2001
Nitrogen monoxide (no) and glucose: unexpected links between energy metabolism and no-mediated iron mobilization from cells.
2001 Feb 16
Expression of gamma-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death.
2001 Feb 9
Effects of phenytoin on glutathione status and oxidative stress biomarker gene mRNA levels in cultured precision human liver slices.
2001 Jan
The activity of NF-kappaB in Swiss 3T3 cells exposed to aqueous extracts of cigarette smoke is dependent on thioredoxin.
2001 Jan
Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites?
2001 Jan
Dual effects of nitric oxide in functional and regressing rat corpus luteum.
2001 Jan
Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury.
2001 Jan
Single amino acid changes outside the active site significantly affect activity of glutathione S-transferases.
2001 Jan
The intracellular oxidation of 2',7'-dichlorofluorescin in murine T lymphocytes.
2001 Jan 1
Thiols can either enhance or suppress DNA damage induction by catecholestrogens.
2001 Jan 1
Differential effects of bcl-2 on cell death triggered under ATP-depleting conditions.
2001 Jan 1
Tamoxifen mutagenesis and carcinogenesis in livers of lambda/lacI transgenic rats: selective influence of phenobarbital promotion.
2001 Jan 10
Catalase in astroglia-rich primary cultures from rat brain: immunocytochemical localization and inactivation during the disposal of hydrogen peroxide.
2001 Jan 12
In vitro binding of ribosomes to the beta subunit of the Sec61p protein translocation complex.
2001 Jan 26
Inhibition of adenylate cyclase activity by 5-aminolevulinic acid in rat and human brain.
2001 Mar
A proteome analysis of the cadmium response in Saccharomyces cerevisiae.
2001 Mar 16
Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1.
2001 Mar 2
The cytosolic O-acetylserine(thiol)lyase gene is regulated by heavy metals and can function in cadmium tolerance.
2001 Mar 23
gamma -glutamyltransferase and its isoform mediate an endoplasmic reticulum stress response.
2001 Mar 23
A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission.
2001 Mar 30
Structural properties and mechanisms that govern association of C kinase adapter 1 with protein kinase C3 and the cell periphery.
2001 Mar 30
A direct inhibitory role for the Rab3-specific effector, Noc2, in Ca2+-regulated exocytosis in neuroendocrine cells.
2001 Mar 30
Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein.
2001 Mar 9
Zinc release from the CH2C6 zinc finger domain of FILAMENTOUS FLOWER protein from Arabidopsis thaliana induces self-assembly.
2001 Mar 9
The putative glutathione peroxidase gene of Plasmodium falciparum codes for a thioredoxin peroxidase.
2001 Mar 9
A genetic investigation of the essential role of glutathione: mutations in the proline biosynthesis pathway are the only suppressors of glutathione auxotrophy in yeast.
2001 Mar 9
Novel G proteins, Rag C and Rag D, interact with GTP-binding proteins, Rag A and Rag B.
2001 Mar 9
Patents

Sample Use Guides

For temporary relief of symptoms related to Free Radical Toxicity: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age. pain in the back from urinating: 10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age. Breast Cancer: RayGel Topical Cream applied in thin layer to the area exposed to radiation 60-90 minutes prior to radiotherapy, standard skin care between treatments. Cystic Fibrosis: Inhaled Reduced Glutathione 10 mg/kg, twice daily, 12 months
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 03:01:48 GMT 2023
Edited
by admin
on Sat Dec 16 03:01:48 GMT 2023
Record UNII
H0X6UKX533
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GLUTATHIONE SODIUM
WHO-DD  
Systematic Name English
REDUCED GLUTATHIONE SODIUM SALT
Common Name English
GLYCINE, L-.GAMMA.-GLUTAMYL-L-CYSTEINYL-, SODIUM SALT
Common Name English
Glutathione sodium [WHO-DD]
Common Name English
Code System Code Type Description
FDA UNII
H0X6UKX533
Created by admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
PRIMARY
SMS_ID
100000078214
Created by admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
PRIMARY
EVMPD
SUB76116
Created by admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
ALTERNATIVE
EVMPD
SUB13991MIG
Created by admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
PRIMARY
PUBCHEM
92043348
Created by admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
PRIMARY
EPA CompTox
DTXSID90955757
Created by admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
PRIMARY
CAS
34212-83-4
Created by admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
NON-SPECIFIC STOICHIOMETRY
CAS
20167-21-9
Created by admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
PRIMARY
ECHA (EC/EINECS)
251-884-1
Created by admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY